The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH

NCT01979471 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

723

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Chronic Kidney Disease
Established Atherosclerotic Vascular Disease
Framingham Risk Score More Than 20 Percent

Interventions

OTHER: Advanced Care

Sponsor

University of Alberta

Collaborators

[object Object]
[object Object]
[object Object]